Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR4A2 | P43354 | 2/20 | 0.69 |
| ▸ | NPC1 | O15118 | 1/20 | 0.63 |
| ▸ | RAB9A | P51151 | 1/20 | 0.63 |
| ▸ | MAOB | P27338 | 4/20 | 0.62 |
| ▸ | MAOA | P21397 | 1/20 | 0.62 |
| ▸ | IDO1 | P14902 | 2/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | RAD52 | P43351 | 1/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7170719 | 0.93 | NR4A2 (0.71) | NR4A2NPC1RAB9AMAOBMAOA | |
| SCHEMBL11849613 | 0.92 | NR4A2 (0.66) | NR4A2NPC1RAB9AMAOBMAOA | |
| SCHEMBL21762 | 0.92 | NR4A2 (0.66) | NR4A2NPC1RAB9AMAOBMAOA | |
| SCHEMBL3618405 | 0.86 | MAPT (0.70) | NR4A2NPC1RAB9AMAOBMAOA | |
| SCHEMBL29001619 | 0.84 | SMN1; SMN2 (0.66) | NR4A2NPC1RAB9AMAOBMAOA | |
| SCHEMBL13483791 | 0.84 | MAOB (0.64) | NR4A2NPC1RAB9AMAOBMAOA | |
| SCHEMBL11093923 | 0.84 | MAOB (0.69) | NR4A2NPC1RAB9AMAOBMAOA | |
| SCHEMBL6408450 | 0.84 | NR4A2 (0.61) | NR4A2NPC1RAB9AMAOBMAOA | |
| SCHEMBL920476 | 0.84 | NR4A2 (0.57) | NR4A2NPC1RAB9AMAOBMAOA | |
| SCHEMBL931875 | 0.84 | PTPRC (0.59) | NR4A2NPC1RAB9AMAOBMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0451201-A1 | PREPARATION OF BIDENTATE LIGANDS | EASTMAN KODAK COMPANY (US) | 1991-10-16 | — | — | EP | claimed |
| WO-1990006930-A1 | PREPARATION OF BIDENTATE LIGANDS | EASTMAN KODAK COMPANY (US) | 1990-06-28 | — | — | WO | claimed |
| EP-0375576-A1 | Preparation of bidentate ligands | EASTMAN KODAK COMPANY (US) | 1990-06-27 | — | — | EP | claimed |
| EP-4067355-A1 | SPIRO-CONDENSED PYRROLIDINE DERIVATIVES AS DEUBIQUITYLATING ENZYME (DUB) INHIBITORS | Mission Therapeutics Limited (GB) | 2022-10-05 | — | — | EP | disclosed |
| EP-3423454-B1 | SPIRO-CONDENSED PYRROLIDINE DERIVATIVES AS DEUBIQUITYLATING ENZYMES (DUB) INHIBITORS | MISSION THERAPEUTICS LTD (GB) | 2022-05-25 | — | — | EP | disclosed |
| US-20220106315-A1 | SPIRO-CONDENSED PYRROLIDINE DERIVATIVES AS DEUBIQUITYLATING ENZYMES (DUB) INHIBITORS | MISSION THERAPEUTICS LTD (GB) | 2022-04-07 | — | — | US | disclosed |
| US-11236092-B2 | Spiro-condensed pyrrolidine derivatives as deubiquitylating enzymes (DUB) inhibitors | MISSION THERAPEUTICS LIMITED (GB) | 2022-02-01 | — | — | US | disclosed |
| US-20200247803-A1 | SPIRO-CONDENSED PYRROLIDINE DERIVATIVES AS DEUBIQUITYLATING ENZYMES (DUB) INHIBITORS | MISSION THERAPEUTICS LIMITED (GB) | 2020-08-06 | — | — | US | disclosed |
| US-10654853-B2 | Spiro-condensed pyrrolidine derivatives as deubiquitylating enzymes (DUB) inhibitors | MISSION THERAPEUTICS LIMITED (GB) | 2020-05-19 | — | — | US | disclosed |
| US-20190048008-A1 | SPIRO-CONDENSED PYRROLIDINE DERIVATIVES AS DEUBIQUITYLATING ENZYMES (DUB) INHIBITORS | MISSION THERAPEUTICS LIMITED (GB) | 2019-02-14 | — | — | US | disclosed |
| EP-1979978-B1 | NONAQUEOUS ELECTROLYTE INCLUDING DIPHENYL ETHER AND LITHIUM SECONDARY BATTERY USING THEREOF | PANAX ETEC CO LTD (KR) | 2016-04-06 | — | — | EP | disclosed |
| EP-0451201-A1 | PREPARATION OF BIDENTATE LIGANDS | EASTMAN KODAK COMPANY (US) | 1991-10-16 | — | — | EP | disclosed |
| WO-1990006930-A1 | PREPARATION OF BIDENTATE LIGANDS | EASTMAN KODAK COMPANY (US) | 1990-06-28 | — | — | WO | disclosed |
| EP-0375576-A1 | Preparation of bidentate ligands | EASTMAN KODAK COMPANY (US) | 1990-06-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220106315-A1 | SPIRO-CONDENSED PYRROLIDINE DERIVATIVES AS DEUBIQUITYLATING ENZYMES (DUB) INHIBITORS | OTUB1, UBE2E1, RCE1 | NR4A2 3046/4885NPC1 2745/4885RAB9A 888/4885 |
| US-20200247803-A1 | SPIRO-CONDENSED PYRROLIDINE DERIVATIVES AS DEUBIQUITYLATING ENZYMES (DUB) INHIBITORS | OTUB1, UBE2E1, RCE1 | NR4A2 3046/4885NPC1 2745/4885RAB9A 888/4885 |
| US-10654853-B2 | Spiro-condensed pyrrolidine derivatives as deubiquitylating enzymes (DUB) inhibitors | OTUB1, UBE2E1, RCE1 | NR4A2 3046/4885NPC1 2745/4885RAB9A 888/4885 |
| US-20190048008-A1 | SPIRO-CONDENSED PYRROLIDINE DERIVATIVES AS DEUBIQUITYLATING ENZYMES (DUB) INHIBITORS | OTUB1, UBE2E1, RCE1 | NR4A2 3046/4885NPC1 2745/4885RAB9A 888/4885 |
| US-11236092-B2 | Spiro-condensed pyrrolidine derivatives as deubiquitylating enzymes (DUB) inhibitors | OTUB1, UBE2E1, RCE1 | NR4A2 3046/4885NPC1 2745/4885RAB9A 888/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.